<div id="readability-page-1"><div><p><span>Rolph Timothy Officer of Akero Therapeutics Inc [AKRO] filed a Form 4 on November 28, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><td><span>Date</span></td><td><span>11/25/25</span></td></tr><tr><td><span>Transaction</span></td><td><span>Exercise(1)</span></td></tr><tr><td><span>Shares</span></td><td><span>152,678</span></td></tr><tr><td><span>Price</span></td><td><span>$4.09</span></td></tr><tr><td><span>Value</span></td><td><span>$624,102</span></td></tr></tbody></table></div><p><span>Ending Holdings: 282,149 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>94,268 shares exercised 2.9 years before expiration date.</span></td></tr><tr><td><span> </span></td><td><span>47,348 shares exercised 4.0 years before expiration date.</span></td></tr><tr><td><span> </span></td><td><span>4,739 shares exercised 6.0 years before expiration date.</span></td></tr><tr><td><span> </span></td><td><span>3,527 shares exercised 5.0 years before expiration date.</span></td></tr><tr><td><span> </span></td><td><span>2,796 shares exercised 2.7 years before expiration date.</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

AKRO

<p>Officer Rolph Timothy of Akero Therapeutics Inc filed a Form 4 with the SEC, disclosing the acquisition of 152,678 shares at $4.09 each, totaling $624,102. The transaction involved exercising options with varying expiration dates, resulting in direct holdings of 282,149 shares. The Washington Service offers insider trading analysis and data services.</p>

Officer Rolph Acquires 152,678 Of Akero Therapeutics Inc [AKRO]